Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -4.97% | 136.25 | 0.0% | $893.93m | |
| AMGN | Amgen, Inc. | 1.12% | 247.50 | 1.5% | $828.95m | |
| GILD | Gilead Sciences, Inc. | 0.90% | 63.84 | 1.0% | $542.01m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.23% | 258.59 | 1.9% | $461.95m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.61% | 661.14 | 2.6% | $422.10m | |
| ILMN | Illumina, Inc. | 1.14% | 243.49 | 3.3% | $313.80m | |
| NVAX | Novavax, Inc. | -8.57% | 53.42 | 75.7% | $307.51m | |
| BIIB | Biogen, Inc. | 3.40% | 199.65 | 1.8% | $240.05m | |
| BNTX | BioNTech SE | -2.90% | 163.00 | 0.0% | $226.41m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 1.93% | 2.11 | 0.7% | $147.50m | |
| EXAS | EXACT Sciences Corp. | -1.54% | 53.17 | 17.7% | $147.09m | |
| TXG | 10X Genomics, Inc. | 0.58% | 50.16 | 0.0% | $101.29m | |
| TECH | Bio-Techne Corp. | -0.03% | 366.35 | 4.5% | $100.80m | |
| NKTX | Nkarta, Inc. | -1.78% | 12.67 | 0.0% | $99.26m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.56% | 79.72 | 4.2% | $98.40m |
Company Profile
Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariépy, and Leigh Revers in 2000 and is headquartered in Austin, TX.